2020年度業績集

原著

  1. Endoscopic and clinicopathological characteristics of colorectal T/NK cell lymphoma.Ishibashi H, Nimura S, Hirai F, Harada N, Iwasaki H, Kawauchi S, Oshiro Y, Matsuyama A, Nakamura S, Takamatsu T, Yonemasu H, Shimokama T, Takeshita M.Diagn Pathol 15(1):128, doi:10.1186, 2020
  2. Systematic review with meta-analysis: efficacy of balloon-assisted enteroscopy for dilation of small bowel Crohn's disease strictures.Dominik Bettenworth, Arne Bokemeyer, Lei Kou, Rocio Lopez, James F Bena, Sara El Ouali, Ren Mao, Satya Kurada, Amit Bhatt, Torsten Beyna, Brendan Halloran, Matthew Reeson, Hosomi S, Kishi M, Hirai F, Ohmiya N, Florian Rieder . Aliment Pharmacol Ther 52(7):1104-1116,2020
  3. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis.Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.J Gastroenterol Hepatol. doi: 10.1111/jgh.15288. Online ahead of print. 2020.
  4. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.Nakase H, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Wagatsuma K, Yokoyama Y, Hisamatsu T.Digestion 4:1-9,2020
  5. Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy.Hata K, Ishihara S, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Kunisaki R, Nakase H, Matsuda K, Iwakiri R, Hida N, Tanaka S, Takeuchi Y, Shinozaki M, Ogata N, Moriichi K, Hirai F, Sugihara K, Hisamatsu T, Suzuki Y, Watanabe M, Hibi T.J Clin Med 9(7):2286-2301,2020
  6. Novel ultrathin double-balloon endoscopy for the diagnosis of small-bowel diseases: a multicenter nonrandomized studyNakamura M, Yano T, Esaki M, Oka S, Mitsui K, Hirai F, Kawasaki K, Fujishiro M, Torisu T, Tanaka S, Iwakiri K, Kishi M, Matsumoto T, Yamamoto H.Endoscopy doi: 10.1055/a-1243-0226. Online ahead of print.　2020
  7. Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab.Yokoyama Y, Sawada K, Aoyama N, Yoshimura N, Sako M, Hirai F, Kashiwagi N, Suzuki YJ Crohns Colitis. 14(9):1264-1273, 2020
  8. Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.Naganuma M, Sugimoto S, Fukuda T, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Abe T, Suzuki Y, Kanai T; INDIGO Study GroupJ Gastroenterol. 55(2):169-180,2020
  9. Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B.Matsumoto A, Nishiguchi S, Enomoto H, Tanaka Y, Shinkai N, Okuse C, Jong-Hon Kang, Matsui T, Miyase S, Yatsuhashi H, Nagaoka S, Kanda T, Enomoto M, Yamada R, Hiramatsu N, Saito S, Takaguchi K, Ito K, Masaki T, Morihara D, Tsuge M, Chayama K, Ikeda F, Kagawa T, Kondo Y, Murata K, Tanaka E.J Gastroenterol 55(10):977-989,2020
  10. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.Tanaka T, Takata K, Kunimoto H, Fukuda H, Yamauchi R, Tsuchiya N, Inomata S, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.Oncology 98(12):859-868,2020
  11. Reduction in Tumor Stain at 2 Weeks after Treatment Initiation Is a Predictor of the Efficacy of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma.Kunimoto H, Shakado S, Tanaka T, Takata K, Yamauchi R, Fukuda H, Tsuchiya N, Yokoyama K, Morihara D, Takeyama Y, Hirai F, Sakisaka S.Oncology 98(11):779-786,2020
  12. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension. Yokoyama K, Tsuchiya N, Yamauchi R, Miyayama T, Uchida Y, Shibata K, Fukuda H, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.Intern Med. 59(17):2089-2094,2020
  13. Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy. Yokoyama K, Irie M, Tsuchiya N, Yamauchi E, Kawashima M, Miyayama T, Fukuda H, Yamauchi R, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.J Gastroenterol Hepatol doi:10.1111/jgh.15259. Online ahead of print.2020 Sep 14.
  14. Plasma Lipid Profiling of Three Types of Drug-Induced Liver Injury in Japanese Patients: A Preliminary Study.Saito K, Kagawa T, Tsuji K, Kumagai Y, Sato K, Sakisaka S, Sakamoto N, Aiso M, Hirose S, Mori N, Tanaka R, Uraoka T, Takata K, Ogawa K, Mori K, Sato M, Nishiya T, Takamatsu K, Arakawa N, Izumi T, Ohno Y, Saito Y, Takikawa H. Metabolites 10(9), 355． doi.org/10.3390/metabo10090355.2020
  15. Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial Kita T, Ashizuka S, Ohmiya N, Yamamoto T, Kanai T, Motoya S, Hirai F, Nakase H, Moriyama T, Nakamura M, Suzuki Y, Kanmura S, Kobayashi T, Ohi H, Nozaki R, Mitsuyama K, Yamamoto S, Inatsu H, Watanabe K, Hibi T, Kitamura K. Journal of Gastroenterology 56(2):147-157,2021
  16. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in miceYamauchi R, Takedatsu H, Yokoyama K, Yamauchi E, Kawashima M, Nagata T, Uchida Y, Kitaguchi T, Higashi T, Fukuda H, Tsuchiya N, Takata K, Tanaka T, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.Hepatol Int. doi:10.1007/s12072-020-10107-0. Online ahead of print. 2021.Jan.
  17. Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysis. Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M.J Gastroenterol Hepatol doi:10.1111/jgh.15401. Online ahead of print.2021 Jan 15.
  18. Intestinal cancer in patients with Crohn's disease: A systematic review and meta-analysis. Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.J Gastroenterol Hepatol 36(2):329-336,2021
  19. Tag-less patency capsule for suspected small bowel stenosis: Nationwide multicenter prospective study in Japan. Nakamura M, Watanabe K, Ohmiya N, Hirai F, Omori T, Tokuhara D, Nakaji K, Nouda S, Esaki M, Sameshima Y, Goto H, Terano A, Tajiri H, Matsui T; J-POP study group.Dig Endosc. 33(1):151-161,2021
  20. Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel -Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation.Sakisaka H, Takedatsu H, Mitsuyama K, Mochizuki S, Sakurai K, Sakisaka S, Hirai F.Int J Mol Sci 21(2):pii: E683. doi: 10.3390/ijms21020683,2020
  21. 福岡大学病院における「免疫抑制・化学療法による発症するB型肝炎ガイドライン」の遵守状況山内　涼、高田和英、森原大輔、大倉野 将広、宮山隆志、土屋直壮、田中　崇、横山圭二、竹山康章、釈迦堂 敏、向坂彰太郎、平井郁仁福岡大学医学紀要 47(1):21-29, 2020
  22. Irregularly branched microvessels as visualized by magnifying endoscopy: a reliable marker for predicting deep submucosal invasion of superficial esophageal squamous cell carcinoma.Ono Y, Takaki Y, Yao K, Ishikawa S, Miyaoka M, Yano Y, Nagahama T, Hisabe T, Hirai F, Ueki T, Ota A, Tanabe H, Haraoka S, Iwashita A, Mikami K, Maekawa T.Endosc Int Open 08(03):E234-E240,2020

症例報告

  1. Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib.Yi-Ling Ko, Takata K, Tanaka T, Ohishi J, Takeshita M, Yamauchi R, Fukuda H, Miyayama T, Uchida Y, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.Case Reports in Gastroenterology 14:226-233, 2020
  2. Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C. Takata K, Ishii F, Uchida Y, Fukuda H, Yamauchi R, Umeda K, Tsuchiya N, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.Intern Med 59（15）:1855-1860,2020
  3. Hepatitis B virus core-related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report.Yokoyama K, Yamauchi E, Uchida Y, Kitaguchi T, Fukuda H, Yamauchi R, Tsuchiya N, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.Clinical Case Reports 8(12):3031-3036,2020
  4. Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate.Yamauchi R, Takeyama Y, Takata K, Fukunaga A, Sakurai K, Tanaka T, Fukuda H, Fukuda S, Kunimoto H, Umeda K, Morihara D, Yokoyama K, Irie M, Shakado S, Sakisaka S and Hirai F. Intern Med 59:1163-1166, 2020
  5. Horizontal Transmission of Hepatitis B Virus Genotype C Among Members of a Wrestling Club in JapanTakata K, Yamauchi E, Shakado S, Uehara Y, Fukuda H, Yamauchi R, Tsuchiya N, Kunimoto H, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Sakisaka S, Hirai F.Am J Case Rep ;21:e925044. doi: 10.12659/AJCR.9250442020 Aug 31
  6. Mass-forming adenomyomatosis in extrahepatic bile ductIshida Y, Okabe Y, Hisaka T, Naito Y, Torimura T.Gastrointestinal Endoscopy 93(2):522-524,2020
  7. 巨大総胆管結石に併発した膵十二指腸動脈瘤破裂による胆道出血の１救命例 安元真希子、荒木俊博、岡部義信、新関　敬、城野智毅、石田祐介、牛島知之、阪上尊彦、鶴田　修、鳥村拓司日本消化器病学会雑誌 117(1):92-98. 2020
  8. A case of episodic angioedema with eosinophilia in an elderly woman with primary biliary cholangitisIwashita H, Shakado S, Yasuda H, Tanabe T, Yamaguchi M, Irie M, Hirai F.Clin J Gastroenterol doi:10.1007/s12328-021-01375-w. Online ahead of print.2021 Mar 10.
  9. Novel Endoscopic Therapy for Gastric Varices Using Direct Forward-Viewing Endoscopic UltrasonographyYokoyama K, Miyayama T, Uchida Y, Fukuda H, Yamauchi R, Tsuchiya N, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.Case Rep Gastroenterol. 15(1):28-34. 2021

総説

  1. クローン病小腸狭窄病変に対するバルーン拡張術平井郁仁INTESTINE 24(3):177-184, 2020
  2. クローン病治療の最先端平井郁仁Medical Science Digest 46(7):10(382)-14(386), 2020
  3. 潰瘍性大腸炎の診断はどのように行い、治療開始するのか？松岡　賢、平井郁仁Medical Practice 37(12):1848-1854,2020
  4. 炎症性腸疾患の診断：臨床医が診断時に注意すべきポイントとは？診断に迷ったらどうする？新規modalityをどう使いこなす？今給黎 宗、石橋英樹、平井郁仁Pharma Medica 38（11）:31-35,2020
  5. COVID-19パンデミック状況下における炎症性腸疾患の管理に関する専門家の意見JAPAN IBD COVID-19 TASKFORCE 厚生労働科学研究費補助金(難治性疾患政策研究事業)難治性炎症性腸管障害に関する調査研究班仲瀬裕志、松本主之、松浦 稔、飯島英樹、松岡克善、大宮直木、石原俊治、平井郁仁、我妻康平、横山佳浩、久松 理一日本消化管学会雑誌 4（1）:15－24,2020
  6. 肝がんに対する肝移植を考慮するタイミング-患者説明のタイミング竹山康章、向坂彰太郎、田中榮司、市田隆文、裵成寛肝癌診療マニュアル　第4版 171-173, 2020
  7. 炎症性腸疾患のモニタリングにおける大腸内視鏡の意義と実際平井郁仁、久能宣昭、阿部光市日本消化器病学会雑誌 118(3):203-211, 2021

著書

  1. 高齢者がん医療Q＆A 総論 第１章　高齢者がんの特徴と評価　3.高齢者でがんを疑ったときの診断的アプローチ・病期決定のための検査　（２）内視鏡検査 Q1.高齢がん患者に対する内視鏡検査を実施するにあたり、その適応・条件は何か？Q2.高齢者がん患者の内視鏡検査の実施にあたって、その留意点は？Q2-1.内視鏡検査にあたって、高齢者の身体的変化に対する留意点は？Q2-2.内視鏡検査にあたって、定期的に服用している抗血栓薬はどうすればいいのか？Q2-3.上部消化管内視鏡検査に伴う偶発症に対する対策は？Q2-4.下部消化管内視鏡検査に伴う偶発症に対する対策は？石橋英樹(分担）日本がんサポーティブケア学会 / 厚生労働科学研究費補助金 がん対策推進総合研究事業 「高齢者がん診療指針策定に必要な基盤整備に関する研究」/ 高齢者がん医療協議会(コンソーシアム) pp.25-34,2020
  2. 高齢者がん医療Q＆A 総論 第6章　低侵襲治療（IVRと内視鏡治療）総論　2.内視鏡治療 Q1. 内視鏡治療に年齢制限はあるか？Q2.高齢者の早期消化管癌に対する内視鏡治療の適応／条件は何か？Q3.高齢者における内視鏡治療でとくに注意すべきことは何か？船越禎広(分担）日本がんサポーティブケア学会 / 厚生労働科学研究費補助金 がん対策推進総合研究事業 「高齢者がん診療指針策定に必要な基盤整備に関する研究」/ 高齢者がん医療協議会(コンソーシアム) pp.147-156,2020

福岡大学医学部 消化器内科 All Rights Reserved, 2019